Literature DB >> 19286466

IGF-1 and G-CSF complement each other in BMSC migration towards infarcted myocardium in a novel in vitro model.

Mohsin Khan1, Sobia Manzoor, Sadia Mohsin, Shaheen N Khan, Fridoon Jawad Ahmad.   

Abstract

Stem cell capability enhanced with cytokine administration is a promising treatment for myocardial infarction. Bone marrow stem cells (BMSCs) were isolated from C57BL/6 mice (8-12 weeks old) expressing GFP and characterized with c-kit and CD34. Infarcted heart tissue fragments were placed into dishes with BMSCs and medium supplemented with G-CSF, SCF, IGF-1 or combinations thereof were given to the BMSC-infarcted myocardium in vitro model. The IGF-1-G-CSF group showed significantly higher migration (67.7% +/- 2.6) of c-kit(+) BMSCs towards the ischemic tissue and expressed MEF-2 (43.7% +/- 1.7). Of the single treatment groups, the G-CSF group demonstrated significantly higher migration of c-kit(+) BMSCs (60.5 +/- 2.7) with MEF-2 expression (38.7 +/- 1.4). IGF-1 complements G-CSF and was relatively more significant in its effects on BMSC migration and cardiac lineage commitment towards ischemic heart tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286466     DOI: 10.1016/j.cellbi.2009.03.002

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  Lin-c-kit(+) BM-derived stem cells repair Infarcted Heart.

Authors:  M Khan; S Mohsin; Sn Khan; S Riazuddin
Journal:  J Stem Cells Regen Med       Date:  2010-04-05

2.  Mobilization efficiency of granulocyte colony-stimulating factor and stem cell factor to bone marrow mononuclear cells and mechanisms.

Authors:  Deyu Duan; Baojun Xiao; Shuhua Yang; Zengwu Shao; Hong Wang; Xiaodong Guo; Yong Liu; Zhewei Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

3.  Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice.

Authors:  Mohsin Khan; Sadia Mohsin; Shaheen N Khan; Sheikh Riazuddin
Journal:  J Cell Mol Med       Date:  2009-12-11       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.